EMS-CHEMIE HOLDING AG (EMSN) - Net Assets

Latest as of June 2025: CHF2.10 Billion CHF

Based on the latest financial reports, EMS-CHEMIE HOLDING AG (EMSN) has net assets worth CHF2.10 Billion CHF as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF2.48 Billion) and total liabilities (CHF375.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF2.10 Billion
% of Total Assets 84.84%
Annual Growth Rate 1.58%
5-Year Change 14.8%
10-Year Change 42.14%
Growth Volatility 9.83

EMS-CHEMIE HOLDING AG - Net Assets Trend (2002–2024)

This chart illustrates how EMS-CHEMIE HOLDING AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for EMS-CHEMIE HOLDING AG (2002–2024)

The table below shows the annual net assets of EMS-CHEMIE HOLDING AG from 2002 to 2024.

Year Net Assets Change
2024-12-31 CHF1.86 Billion +5.43%
2023-12-31 CHF1.77 Billion -4.11%
2022-12-31 CHF1.84 Billion +0.88%
2021-12-31 CHF1.83 Billion +12.56%
2020-12-31 CHF1.62 Billion -3.64%
2019-12-31 CHF1.69 Billion +2.49%
2018-12-31 CHF1.64 Billion +6.08%
2017-12-31 CHF1.55 Billion +8.59%
2016-12-31 CHF1.43 Billion +8.84%
2015-12-31 CHF1.31 Billion +3.44%
2014-12-31 CHF1.27 Billion +5.74%
2013-12-31 CHF1.20 Billion +4.18%
2012-12-31 CHF1.15 Billion +8.96%
2011-12-31 CHF1.06 Billion -4.85%
2010-12-31 CHF1.11 Billion +8.68%
2009-12-31 CHF1.02 Billion +4.76%
2008-12-31 CHF975.30 Million -23.60%
2007-12-31 CHF1.28 Billion +15.77%
2006-12-31 CHF1.10 Billion +1.83%
2005-12-31 CHF1.08 Billion -3.16%
2004-12-31 CHF1.12 Billion -24.25%
2003-12-31 CHF1.48 Billion +11.84%
2002-12-31 CHF1.32 Billion --

Equity Component Analysis

This analysis shows how different components contribute to EMS-CHEMIE HOLDING AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 58.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CHF2.01 Billion 109.39%
Common Stock CHF234.00K 0.01%
Other Comprehensive Income CHF-198.25 Million -10.80%
Other Components CHF25.68 Million 1.40%
Total Equity CHF1.83 Billion 100.00%

EMS-CHEMIE HOLDING AG Competitors by Market Cap

The table below lists competitors of EMS-CHEMIE HOLDING AG ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EMS-CHEMIE HOLDING AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,741,818,000 to 1,834,940,000, a change of 93,122,000 (5.3%).
  • Net income of 460,788,000 contributed positively to equity growth.
  • Dividend payments of 374,224,000 reduced retained earnings.
  • Other comprehensive income increased equity by 8,203,001.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CHF460.79 Million +25.11%
Dividends Paid CHF374.22 Million -20.39%
Other Comprehensive Income CHF8.20 Million +0.45%
Other Changes CHF-1.65 Million -0.09%
Total Change CHF- 5.35%

Book Value vs Market Value Analysis

This analysis compares EMS-CHEMIE HOLDING AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.60x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 13.66x to 8.60x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 CHF49.40 CHF675.00 x
2003-12-31 CHF55.23 CHF675.00 x
2004-12-31 CHF44.56 CHF675.00 x
2005-12-31 CHF39.15 CHF675.00 x
2006-12-31 CHF41.80 CHF675.00 x
2007-12-31 CHF52.32 CHF675.00 x
2008-12-31 CHF41.95 CHF675.00 x
2009-12-31 CHF44.91 CHF675.00 x
2010-12-31 CHF47.16 CHF675.00 x
2011-12-31 CHF44.53 CHF675.00 x
2012-12-31 CHF48.59 CHF675.00 x
2013-12-31 CHF50.68 CHF675.00 x
2014-12-31 CHF53.47 CHF675.00 x
2015-12-31 CHF55.18 CHF675.00 x
2016-12-31 CHF60.09 CHF675.00 x
2017-12-31 CHF65.20 CHF675.00 x
2018-12-31 CHF69.48 CHF675.00 x
2019-12-31 CHF71.09 CHF675.00 x
2020-12-31 CHF68.31 CHF675.00 x
2021-12-31 CHF76.91 CHF675.00 x
2022-12-31 CHF77.63 CHF675.00 x
2023-12-31 CHF74.47 CHF675.00 x
2024-12-31 CHF78.45 CHF675.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EMS-CHEMIE HOLDING AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 25.11%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 22.25%
  • • Asset Turnover: 0.93x
  • • Equity Multiplier: 1.21x
  • Recent ROE (25.11%) is above the historical average (24.68%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 12.79% 12.33% 0.42x 2.46x CHF36.00 Million
2003 7.87% 8.57% 0.42x 2.16x CHF-30.76 Million
2004 16.97% 15.96% 0.44x 2.40x CHF75.34 Million
2005 17.01% 14.13% 0.53x 2.26x CHF73.01 Million
2006 28.20% 21.31% 0.60x 2.21x CHF191.95 Million
2007 23.32% 18.31% 0.70x 1.81x CHF167.80 Million
2008 22.42% 13.80% 0.93x 1.75x CHF119.20 Million
2009 22.02% 18.73% 0.69x 1.70x CHF120.74 Million
2010 21.16% 14.55% 0.96x 1.52x CHF122.41 Million
2011 23.25% 14.61% 1.01x 1.57x CHF138.01 Million
2012 23.50% 15.21% 1.05x 1.48x CHF153.38 Million
2013 26.81% 16.55% 1.10x 1.47x CHF199.13 Million
2014 27.43% 17.12% 1.09x 1.48x CHF217.86 Million
2015 29.16% 19.48% 1.02x 1.47x CHF247.22 Million
2016 31.94% 22.31% 1.01x 1.41x CHF308.26 Million
2017 31.58% 22.12% 1.04x 1.38x CHF329.02 Million
2018 31.97% 22.12% 1.09x 1.33x CHF357.11 Million
2019 31.70% 24.49% 0.97x 1.33x CHF360.87 Million
2020 27.18% 24.10% 0.87x 1.30x CHF274.56 Million
2021 30.59% 24.42% 0.97x 1.29x CHF370.43 Million
2022 29.30% 21.79% 1.05x 1.28x CHF350.52 Million
2023 26.27% 20.90% 1.01x 1.24x CHF283.40 Million
2024 25.11% 22.25% 0.93x 1.21x CHF277.29 Million

Industry Comparison

This section compares EMS-CHEMIE HOLDING AG's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $1,828,168,750
  • Average return on equity (ROE) among peers: 9.67%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EMS-CHEMIE HOLDING AG (EMSN) CHF2.10 Billion 12.79% 0.18x $14.92 Billion
Clariant AG (CLN) $2.31 Billion 6.57% 2.50x $2.41 Billion
Givaudan SA (GIVN) $2.68 Billion 3.50% 1.94x $25.74 Billion
Gurit Holding AG (GURN) $179.47 Million 12.58% 0.40x $119.06 Million
Sika AG (SIKA) $2.14 Billion 16.02% 1.22x $25.37 Billion

About EMS-CHEMIE HOLDING AG

SW:EMSN Switzerland Specialty Chemicals
Market Cap
$19.96 Billion
CHF15.79 Billion CHF
Market Cap Rank
#1466 Global
#21 in Switzerland
Share Price
CHF675.00
Change (1 day)
+0.97%
52-Week Range
CHF531.50 - CHF675.00
All Time High
CHF1020.89
About

EMS-CHEMIE HOLDING AG engages in the polymers and specialty chemicals businesses in the Americas, Europe, Asia, and internationally. It is involved in the manufacturing and supply of high-performance polyamide granulate, as well as develops, produces, and sells fibers, fusible adhesives, and adhesive yarns for technical and textile applications, powder coatings, and reactive diluents. The company… Read more